top
Search terms
Results 1 - 2 of 2 - ordered by :
Escardio

The primary endpoint-prevention of reduction in EF of ≥10 percentage points from baseline to 6 months was not reached (about 14% in both the carvedilol and placebo group), but the carvedilol group ...

Date : 30/11/2018
Escardio

Atrial fibrillation is currently the most common cardiac arrhythmia and is a major risk factor for heart failure (risk tripled), stroke (risk increased up to five times) and overall mortality (risk ...

Date : 15/05/2012